For example, Zepbound (tirzepatide) and Saxenda (liraglutide) are other meds approved by the US Food and Drug Administration (FDA) for weight loss
[Accessed on 11 June 2026] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial (2023)
This is substantially higher than with the highest dose of Rybelsus, where people lost an average of 4% of body weight
35 Fueling Your Muscles: The Power of Protein Exercise provides the stimulus for muscle maintenance and growth, but protein provides the essential building materials
Study 1 was conducted during the light phase
Healthcare professionals are advised to maintain vigilance for adverse effects including pancreatitis, gallbladder complications, and changes in renal function